NCCN 2023 Breast Cancer Congress with Updates from the 2022 San Antonio Breast Cancer Symposium

February 3, 2023

This program will provide expert insights on the current recommendations of care for patients with breast cancer and include the latest clinical research updates to assist clinicians in formulating breast cancer management strategies.

Target Audience

This educational program is designed to meet the educational needs of physicians, nurse practitioners, nurses, PAs, pharmacists, and other health care professionals who manage patients with breast cancer.

Learning Objectives

The ultimate goal for NCCN continuing education is to change patient outcomes by improving the competence and performance of clinicians. The goal of the NCCN 2023 Breast Cancer Congress with Updates from the 2022 San Antonio Breast Cancer Symposium is to ensure that members of the interprofessional oncology care team have the knowledge and skills necessary to: 

  • Summarize the current standards of oncology care, key updates in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), and clinical research updates from the 2022 San Antonio Breast Cancer Symposium (SABCS), and integrate appropriate strategies into clinical practice to optimize the management of patients with breast cancer.
  • Evaluate new, emerging and novel therapeutic agents, advances in care, and clinical trials data and apply relevant findings into the management of patients with breast cancer. 

Click here to view the learning objectives for each individual session.

Additional information
Supporters: 

This activity is supported by educational grants from:

  • AstraZeneca
  • Exact Sciences
  • Gilead Sciences, Inc.
  • Lilly
  • Novartis
  • Puma Biotechnology
  • Seagen

This activity is supported by independent educational grants from:

  • Daiichi Sankyo 
  • Merck & Co., Inc. 

This activity is supported independent medical education grants from:

  • Organon
  • Pfizer Inc. 
Course summary
Available credit: 
  • 5.75 AAPA Category 1 CME credit
  • 5.75 ACPE contact hours
  • 5.75 AMA PRA Category 1 Credit™
  • 5.75 ANCC contact hours
    • 3.00 ANCC Pharmacology Contact Hours
  • 5.75 Participation
Course opens: 
02/03/2023
Course expires: 
05/07/2023
Event starts: 
02/03/2023 - 10:00am EST
Event ends: 
02/03/2023 - 5:30pm EST
Cost:
$0.00

NCCN Continuing Education Disclosure Policy
It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing. 

Definitions  

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers  

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.

Full disclosure of faculty relationships will be made prior to the activity.

In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
NCCN designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
NCCN designates this educational activity for a maximum of 5.75 contact hours. This program offers 3 pharmacotherapeutic contact hours for nurses.

Pharmacists

NCCN designates this knowledge-based continuing education activity for 5.75 contact hours (0.575 CEUs) of continuing education credit. UAN: JA4008196-0000-23-013-L01-P

PAs
NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.75 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Aggregated participant data will be shared with the commercial supporters of this activity.

American Board of Pathology Continuing Certification (CC)

This activity has been registered to offer credit in the American Board of Pathology’s (ABPath) Continuing Certification program. Successful completion of this CME activity enables the participant to earn up to 5.75 Lifelong Learning (Part II) credits.

Aggregated participant data will be shared with the commercial supporters of this activity.

American Board of Surgery Continuous Certification (CC)


Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

American Board of Medical Specialties (MOC)
Through the American Board of Medical Specialties (“ABMS”) MOC Initiative to create a wide array of Maintenance of Certification (“MOC”) Activities through the ABMS MOC Directory, the NCCN 2023 Breast Cancer Congress has met the MOC requirements as a  MOC Part II CME Activity (apply toward general CME requirement) by the following ABMS Member Boards:

MOC Part II CME Activity
Medical Genetics and Genomics
Pathology
Radiology

Available Credit

  • 5.75 AAPA Category 1 CME credit
  • 5.75 ACPE contact hours
  • 5.75 AMA PRA Category 1 Credit™
  • 5.75 ANCC contact hours
    • 3.00 ANCC Pharmacology Contact Hours
  • 5.75 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Click the Take Course button to start the credit claiming process.

CE/MOC credit should be claimed for the congress as a whole, not session by session. You may claim credit for the congress only one time. When calculating your total credits, you should take into account all of the sessions you viewed either live or via recording. (Please note that you have access to all of the session recordings for 60 days after the live congress.) 

Pharmacists: you must complete all requirements for credit by March 20, 2023.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing